Loading...
Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3
BACKGROUND: The genes of SPARC, CCR2, and SMAD3 are implicated in orchestrating inflammatory response that leads to fibrosis in scleroderma and other fibrotic disorders. The aim of the studies is to evaluate synergistic anti-fibrotic potency of the siRNAs of these genes. METHODS: The efficacy of the...
Saved in:
| Published in: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6306344/ https://ncbi.nlm.nih.gov/pubmed/30470612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.11.016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|